by Sarah C.p. Williams, Gladstone Institutes A new study by Gladstone scientists suggests that certain anti-epileptic or tau-reducing treatments could be promising for people in the early stages of Alzheimer’s disease. Credit: Michael Short / Gladstone Institutes Studying the complex causes of Alzheimer’s disease, and how to treat and prevent this condition, is like solving a...
